BeiGene Ltd (BGNE) reported a Q4 net loss Thursday of $1.43 per American depositary share, narrowing from $3.53 per share a year earlier.
Analysts polled by FactSet expected a loss of $1.01.
Revenue for the quarter ended Dec. 31 was $1.13 billion, up from $634.4 million a year earlier.
Analysts surveyed by FactSet expected $1.04 billion.
The company expects full year revenue between $4.9 billion and $5.3 billion.
Analysts polled by FactSet expect $4.73 billion.
BeiGene shares were up more than 3% in recent Thursday premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。